世界の麻痺（プレジア）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Paralysis (Plegia) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4654
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、121ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、麻痺（プレジア）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（理学療法、医薬品、その他）、用途別市場規模（病院、専門クリニック、外来手術センター、在宅医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・麻痺（プレジア）治療の市場動向
・企業の競争状況、市場シェア
・麻痺（プレジア）治療の種類別市場規模と予測2016-2027（理学療法、医薬品、その他）
・麻痺（プレジア）治療の用途別市場規模と予測2016-2027（病院、専門クリニック、外来手術センター、在宅医療、その他）
・麻痺（プレジア）治療の北米市場規模2016-2027（アメリカ、カナダ）
・麻痺（プレジア）治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・麻痺（プレジア）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・麻痺（プレジア）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・麻痺（プレジア）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Strongbridge Biopharma plc、Sun Pharmaceutical Industries Ltd、Heritage、Mylan N.V.、Zydus Cadila、Alembic Pharmaceuticals Limited、Teva Pharmaceutical Industries Ltd、X-GEN Pharmaceuticals, Inc、Cyberonics, Inc.、Novartis AG、Astellas Pharma Inc.、Mallinckrodt、Stryker、Teleflex Incorporated、Acclarent, Inc. (Johnson & Johnson)、Medtronic）
・結論

Market Analysis and Insights: Global Paralysis (Plegia) Treatment Market
The global Paralysis (Plegia) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Paralysis (Plegia) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Paralysis (Plegia) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Paralysis (Plegia) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Paralysis (Plegia) Treatment market.

Global Paralysis (Plegia) Treatment Scope and Market Size
Paralysis (Plegia) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Paralysis (Plegia) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Physical Therapy
Medications
Others

Segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Homecare
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Strongbridge Biopharma plc
Sun Pharmaceutical Industries Ltd
Heritage
Mylan N.V.
Zydus Cadila
Alembic Pharmaceuticals Limited
Teva Pharmaceutical Industries Ltd
X-GEN Pharmaceuticals, Inc
Cyberonics, Inc.
Novartis AG
Astellas Pharma Inc.
Mallinckrodt
Stryker
Teleflex Incorporated
Acclarent, Inc. (Johnson & Johnson)
Medtronic

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paralysis (Plegia) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Physical Therapy
1.2.3 Medications
1.2.4 Others
1.3 Market by Application
1.3.1 Global Paralysis (Plegia) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Homecare
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Paralysis (Plegia) Treatment Market Perspective (2016-2027)
2.2 Paralysis (Plegia) Treatment Growth Trends by Regions
2.2.1 Paralysis (Plegia) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Paralysis (Plegia) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Paralysis (Plegia) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Paralysis (Plegia) Treatment Industry Dynamic
2.3.1 Paralysis (Plegia) Treatment Market Trends
2.3.2 Paralysis (Plegia) Treatment Market Drivers
2.3.3 Paralysis (Plegia) Treatment Market Challenges
2.3.4 Paralysis (Plegia) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Paralysis (Plegia) Treatment Players by Revenue
3.1.1 Global Top Paralysis (Plegia) Treatment Players by Revenue (2016-2021)
3.1.2 Global Paralysis (Plegia) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Paralysis (Plegia) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Paralysis (Plegia) Treatment Revenue
3.4 Global Paralysis (Plegia) Treatment Market Concentration Ratio
3.4.1 Global Paralysis (Plegia) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paralysis (Plegia) Treatment Revenue in 2020
3.5 Paralysis (Plegia) Treatment Key Players Head office and Area Served
3.6 Key Players Paralysis (Plegia) Treatment Product Solution and Service
3.7 Date of Enter into Paralysis (Plegia) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Paralysis (Plegia) Treatment Breakdown Data by Type
4.1 Global Paralysis (Plegia) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Paralysis (Plegia) Treatment Forecasted Market Size by Type (2022-2027)

5 Paralysis (Plegia) Treatment Breakdown Data by Application
5.1 Global Paralysis (Plegia) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Paralysis (Plegia) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Paralysis (Plegia) Treatment Market Size (2016-2027)
6.2 North America Paralysis (Plegia) Treatment Market Size by Type
6.2.1 North America Paralysis (Plegia) Treatment Market Size by Type (2016-2021)
6.2.2 North America Paralysis (Plegia) Treatment Market Size by Type (2022-2027)
6.2.3 North America Paralysis (Plegia) Treatment Market Size by Type (2016-2027)
6.3 North America Paralysis (Plegia) Treatment Market Size by Application
6.3.1 North America Paralysis (Plegia) Treatment Market Size by Application (2016-2021)
6.3.2 North America Paralysis (Plegia) Treatment Market Size by Application (2022-2027)
6.3.3 North America Paralysis (Plegia) Treatment Market Size by Application (2016-2027)
6.4 North America Paralysis (Plegia) Treatment Market Size by Country
6.4.1 North America Paralysis (Plegia) Treatment Market Size by Country (2016-2021)
6.4.2 North America Paralysis (Plegia) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Paralysis (Plegia) Treatment Market Size (2016-2027)
7.2 Europe Paralysis (Plegia) Treatment Market Size by Type
7.2.1 Europe Paralysis (Plegia) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Paralysis (Plegia) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Paralysis (Plegia) Treatment Market Size by Type (2016-2027)
7.3 Europe Paralysis (Plegia) Treatment Market Size by Application
7.3.1 Europe Paralysis (Plegia) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Paralysis (Plegia) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Paralysis (Plegia) Treatment Market Size by Application (2016-2027)
7.4 Europe Paralysis (Plegia) Treatment Market Size by Country
7.4.1 Europe Paralysis (Plegia) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Paralysis (Plegia) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Paralysis (Plegia) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Paralysis (Plegia) Treatment Market Size by Type
8.2.1 Asia-Pacific Paralysis (Plegia) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Paralysis (Plegia) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Paralysis (Plegia) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Paralysis (Plegia) Treatment Market Size by Application
8.3.1 Asia-Pacific Paralysis (Plegia) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Paralysis (Plegia) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Paralysis (Plegia) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Paralysis (Plegia) Treatment Market Size by Region
8.4.1 Asia-Pacific Paralysis (Plegia) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Paralysis (Plegia) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Paralysis (Plegia) Treatment Market Size (2016-2027)
9.2 Latin America Paralysis (Plegia) Treatment Market Size by Type
9.2.1 Latin America Paralysis (Plegia) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Paralysis (Plegia) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Paralysis (Plegia) Treatment Market Size by Type (2016-2027)
9.3 Latin America Paralysis (Plegia) Treatment Market Size by Application
9.3.1 Latin America Paralysis (Plegia) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Paralysis (Plegia) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Paralysis (Plegia) Treatment Market Size by Application (2016-2027)
9.4 Latin America Paralysis (Plegia) Treatment Market Size by Country
9.4.1 Latin America Paralysis (Plegia) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Paralysis (Plegia) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Paralysis (Plegia) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Paralysis (Plegia) Treatment Market Size by Type
10.2.1 Middle East & Africa Paralysis (Plegia) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Paralysis (Plegia) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Paralysis (Plegia) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Paralysis (Plegia) Treatment Market Size by Application
10.3.1 Middle East & Africa Paralysis (Plegia) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Paralysis (Plegia) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Paralysis (Plegia) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Paralysis (Plegia) Treatment Market Size by Country
10.4.1 Middle East & Africa Paralysis (Plegia) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Paralysis (Plegia) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Strongbridge Biopharma plc
11.1.1 Strongbridge Biopharma plc Company Details
11.1.2 Strongbridge Biopharma plc Business Overview
11.1.3 Strongbridge Biopharma plc Paralysis (Plegia) Treatment Introduction
11.1.4 Strongbridge Biopharma plc Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.1.5 Strongbridge Biopharma plc Recent Development
11.2 Sun Pharmaceutical Industries Ltd
11.2.1 Sun Pharmaceutical Industries Ltd Company Details
11.2.2 Sun Pharmaceutical Industries Ltd Business Overview
11.2.3 Sun Pharmaceutical Industries Ltd Paralysis (Plegia) Treatment Introduction
11.2.4 Sun Pharmaceutical Industries Ltd Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.2.5 Sun Pharmaceutical Industries Ltd Recent Development
11.3 Heritage
11.3.1 Heritage Company Details
11.3.2 Heritage Business Overview
11.3.3 Heritage Paralysis (Plegia) Treatment Introduction
11.3.4 Heritage Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.3.5 Heritage Recent Development
11.4 Mylan N.V.
11.4.1 Mylan N.V. Company Details
11.4.2 Mylan N.V. Business Overview
11.4.3 Mylan N.V. Paralysis (Plegia) Treatment Introduction
11.4.4 Mylan N.V. Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.4.5 Mylan N.V. Recent Development
11.5 Zydus Cadila
11.5.1 Zydus Cadila Company Details
11.5.2 Zydus Cadila Business Overview
11.5.3 Zydus Cadila Paralysis (Plegia) Treatment Introduction
11.5.4 Zydus Cadila Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.5.5 Zydus Cadila Recent Development
11.6 Alembic Pharmaceuticals Limited
11.6.1 Alembic Pharmaceuticals Limited Company Details
11.6.2 Alembic Pharmaceuticals Limited Business Overview
11.6.3 Alembic Pharmaceuticals Limited Paralysis (Plegia) Treatment Introduction
11.6.4 Alembic Pharmaceuticals Limited Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.6.5 Alembic Pharmaceuticals Limited Recent Development
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Company Details
11.7.2 Teva Pharmaceutical Industries Ltd Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd Paralysis (Plegia) Treatment Introduction
11.7.4 Teva Pharmaceutical Industries Ltd Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.7.5 Teva Pharmaceutical Industries Ltd Recent Development
11.8 X-GEN Pharmaceuticals, Inc
11.8.1 X-GEN Pharmaceuticals, Inc Company Details
11.8.2 X-GEN Pharmaceuticals, Inc Business Overview
11.8.3 X-GEN Pharmaceuticals, Inc Paralysis (Plegia) Treatment Introduction
11.8.4 X-GEN Pharmaceuticals, Inc Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.8.5 X-GEN Pharmaceuticals, Inc Recent Development
11.9 Cyberonics, Inc.
11.9.1 Cyberonics, Inc. Company Details
11.9.2 Cyberonics, Inc. Business Overview
11.9.3 Cyberonics, Inc. Paralysis (Plegia) Treatment Introduction
11.9.4 Cyberonics, Inc. Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.9.5 Cyberonics, Inc. Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Paralysis (Plegia) Treatment Introduction
11.10.4 Novartis AG Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.10.5 Novartis AG Recent Development
11.11 Astellas Pharma Inc.
11.11.1 Astellas Pharma Inc. Company Details
11.11.2 Astellas Pharma Inc. Business Overview
11.11.3 Astellas Pharma Inc. Paralysis (Plegia) Treatment Introduction
11.11.4 Astellas Pharma Inc. Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.11.5 Astellas Pharma Inc. Recent Development
11.12 Mallinckrodt
11.12.1 Mallinckrodt Company Details
11.12.2 Mallinckrodt Business Overview
11.12.3 Mallinckrodt Paralysis (Plegia) Treatment Introduction
11.12.4 Mallinckrodt Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.12.5 Mallinckrodt Recent Development
11.13 Stryker
11.13.1 Stryker Company Details
11.13.2 Stryker Business Overview
11.13.3 Stryker Paralysis (Plegia) Treatment Introduction
11.13.4 Stryker Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.13.5 Stryker Recent Development
11.14 Teleflex Incorporated
11.14.1 Teleflex Incorporated Company Details
11.14.2 Teleflex Incorporated Business Overview
11.14.3 Teleflex Incorporated Paralysis (Plegia) Treatment Introduction
11.14.4 Teleflex Incorporated Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.14.5 Teleflex Incorporated Recent Development
11.15 Acclarent, Inc. (Johnson & Johnson)
11.15.1 Acclarent, Inc. (Johnson & Johnson) Company Details
11.15.2 Acclarent, Inc. (Johnson & Johnson) Business Overview
11.15.3 Acclarent, Inc. (Johnson & Johnson) Paralysis (Plegia) Treatment Introduction
11.15.4 Acclarent, Inc. (Johnson & Johnson) Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.15.5 Acclarent, Inc. (Johnson & Johnson) Recent Development
11.16 Medtronic
11.16.1 Medtronic Company Details
11.16.2 Medtronic Business Overview
11.16.3 Medtronic Paralysis (Plegia) Treatment Introduction
11.16.4 Medtronic Revenue in Paralysis (Plegia) Treatment Business (2016-2021)
11.16.5 Medtronic Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Paralysis (Plegia) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Physical Therapy
Table 3. Key Players of Medications
Table 4. Key Players of Others
Table 5. Global Paralysis (Plegia) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Paralysis (Plegia) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Paralysis (Plegia) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Paralysis (Plegia) Treatment Market Share by Regions (2016-2021)
Table 9. Global Paralysis (Plegia) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Paralysis (Plegia) Treatment Market Share by Regions (2022-2027)
Table 11. Paralysis (Plegia) Treatment Market Trends
Table 12. Paralysis (Plegia) Treatment Market Drivers
Table 13. Paralysis (Plegia) Treatment Market Challenges
Table 14. Paralysis (Plegia) Treatment Market Restraints
Table 15. Global Paralysis (Plegia) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Paralysis (Plegia) Treatment Market Share by Players (2016-2021)
Table 17. Global Top Paralysis (Plegia) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paralysis (Plegia) Treatment as of 2020)
Table 18. Ranking of Global Top Paralysis (Plegia) Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Paralysis (Plegia) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Paralysis (Plegia) Treatment Product Solution and Service
Table 22. Date of Enter into Paralysis (Plegia) Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Paralysis (Plegia) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Paralysis (Plegia) Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Paralysis (Plegia) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Paralysis (Plegia) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Paralysis (Plegia) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Paralysis (Plegia) Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Paralysis (Plegia) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Paralysis (Plegia) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Paralysis (Plegia) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Paralysis (Plegia) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Paralysis (Plegia) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Paralysis (Plegia) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Paralysis (Plegia) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Paralysis (Plegia) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Paralysis (Plegia) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Paralysis (Plegia) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Paralysis (Plegia) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Paralysis (Plegia) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Paralysis (Plegia) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Paralysis (Plegia) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Paralysis (Plegia) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Paralysis (Plegia) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Paralysis (Plegia) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Paralysis (Plegia) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Paralysis (Plegia) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Paralysis (Plegia) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Paralysis (Plegia) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Paralysis (Plegia) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Paralysis (Plegia) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Paralysis (Plegia) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Paralysis (Plegia) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Paralysis (Plegia) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Paralysis (Plegia) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Paralysis (Plegia) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Paralysis (Plegia) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Paralysis (Plegia) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Paralysis (Plegia) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Paralysis (Plegia) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Strongbridge Biopharma plc Company Details
Table 63. Strongbridge Biopharma plc Business Overview
Table 64. Strongbridge Biopharma plc Paralysis (Plegia) Treatment Product
Table 65. Strongbridge Biopharma plc Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 66. Strongbridge Biopharma plc Recent Development
Table 67. Sun Pharmaceutical Industries Ltd Company Details
Table 68. Sun Pharmaceutical Industries Ltd Business Overview
Table 69. Sun Pharmaceutical Industries Ltd Paralysis (Plegia) Treatment Product
Table 70. Sun Pharmaceutical Industries Ltd Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 71. Sun Pharmaceutical Industries Ltd Recent Development
Table 72. Heritage Company Details
Table 73. Heritage Business Overview
Table 74. Heritage Paralysis (Plegia) Treatment Product
Table 75. Heritage Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 76. Heritage Recent Development
Table 77. Mylan N.V. Company Details
Table 78. Mylan N.V. Business Overview
Table 79. Mylan N.V. Paralysis (Plegia) Treatment Product
Table 80. Mylan N.V. Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 81. Mylan N.V. Recent Development
Table 82. Zydus Cadila Company Details
Table 83. Zydus Cadila Business Overview
Table 84. Zydus Cadila Paralysis (Plegia) Treatment Product
Table 85. Zydus Cadila Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 86. Zydus Cadila Recent Development
Table 87. Alembic Pharmaceuticals Limited Company Details
Table 88. Alembic Pharmaceuticals Limited Business Overview
Table 89. Alembic Pharmaceuticals Limited Paralysis (Plegia) Treatment Product
Table 90. Alembic Pharmaceuticals Limited Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 91. Alembic Pharmaceuticals Limited Recent Development
Table 92. Teva Pharmaceutical Industries Ltd Company Details
Table 93. Teva Pharmaceutical Industries Ltd Business Overview
Table 94. Teva Pharmaceutical Industries Ltd Paralysis (Plegia) Treatment Product
Table 95. Teva Pharmaceutical Industries Ltd Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 96. Teva Pharmaceutical Industries Ltd Recent Development
Table 97. X-GEN Pharmaceuticals, Inc Company Details
Table 98. X-GEN Pharmaceuticals, Inc Business Overview
Table 99. X-GEN Pharmaceuticals, Inc Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 100. X-GEN Pharmaceuticals, Inc Recent Development
Table 101. Cyberonics, Inc. Company Details
Table 102. Cyberonics, Inc. Business Overview
Table 103. Cyberonics, Inc. Paralysis (Plegia) Treatment Product
Table 104. Cyberonics, Inc. Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 105. Cyberonics, Inc. Recent Development
Table 106. Novartis AG Company Details
Table 107. Novartis AG Business Overview
Table 108. Novartis AG Paralysis (Plegia) Treatment Product
Table 109. Novartis AG Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 110. Novartis AG Recent Development
Table 111. Astellas Pharma Inc. Company Details
Table 112. Astellas Pharma Inc. Business Overview
Table 113. Astellas Pharma Inc. Paralysis (Plegia) Treatment Product
Table 114. Astellas Pharma Inc. Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 115. Astellas Pharma Inc. Recent Development
Table 116. Mallinckrodt Company Details
Table 117. Mallinckrodt Business Overview
Table 118. Mallinckrodt Paralysis (Plegia) Treatment Product
Table 119. Mallinckrodt Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 120. Mallinckrodt Recent Development
Table 121. Stryker Company Details
Table 122. Stryker Business Overview
Table 123. Stryker Paralysis (Plegia) Treatment Product
Table 124. Stryker Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 125. Stryker Recent Development
Table 126. Teleflex Incorporated Company Details
Table 127. Teleflex Incorporated Business Overview
Table 128. Teleflex Incorporated Paralysis (Plegia) Treatment Product
Table 129. Teleflex Incorporated Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 130. Teleflex Incorporated Recent Development
Table 131. Acclarent, Inc. (Johnson & Johnson) Company Details
Table 132. Acclarent, Inc. (Johnson & Johnson) Business Overview
Table 133. Acclarent, Inc. (Johnson & Johnson) Paralysis (Plegia) Treatment Product
Table 134. Acclarent, Inc. (Johnson & Johnson) Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 135. Acclarent, Inc. (Johnson & Johnson) Recent Development
Table 136. Medtronic Company Details
Table 137. Medtronic Business Overview
Table 138. Medtronic Paralysis (Plegia) Treatment Product
Table 139. Medtronic Revenue in Paralysis (Plegia) Treatment Business (2016-2021) & (US$ Million)
Table 140. Medtronic Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paralysis (Plegia) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Physical Therapy Features
Figure 3. Medications Features
Figure 4. Others Features
Figure 5. Global Paralysis (Plegia) Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Homecare Case Studies
Figure 10. Others Case Studies
Figure 11. Paralysis (Plegia) Treatment Report Years Considered
Figure 12. Global Paralysis (Plegia) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Paralysis (Plegia) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Paralysis (Plegia) Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Paralysis (Plegia) Treatment Market Share by Regions (2022-2027)
Figure 16. Global Paralysis (Plegia) Treatment Market Share by Players in 2020
Figure 17. Global Top Paralysis (Plegia) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paralysis (Plegia) Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Paralysis (Plegia) Treatment Revenue in 2020
Figure 19. Global Paralysis (Plegia) Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Paralysis (Plegia) Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Paralysis (Plegia) Treatment Market Share by Type (2016-2027)
Figure 23. North America Paralysis (Plegia) Treatment Market Share by Application (2016-2027)
Figure 24. North America Paralysis (Plegia) Treatment Market Share by Country (2016-2027)
Figure 25. United States Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Paralysis (Plegia) Treatment Market Share by Type (2016-2027)
Figure 29. Europe Paralysis (Plegia) Treatment Market Share by Application (2016-2027)
Figure 30. Europe Paralysis (Plegia) Treatment Market Share by Country (2016-2027)
Figure 31. Germany Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Paralysis (Plegia) Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Paralysis (Plegia) Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Paralysis (Plegia) Treatment Market Share by Region (2016-2027)
Figure 41. China Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Paralysis (Plegia) Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Paralysis (Plegia) Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Paralysis (Plegia) Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Paralysis (Plegia) Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Paralysis (Plegia) Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Paralysis (Plegia) Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Paralysis (Plegia) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Strongbridge Biopharma plc Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 61. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 62. Heritage Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 63. Mylan N.V. Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 64. Zydus Cadila Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 65. Alembic Pharmaceuticals Limited Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 66. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 67. X-GEN Pharmaceuticals, Inc Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 68. Cyberonics, Inc. Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 69. Novartis AG Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 70. Astellas Pharma Inc. Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 71. Mallinckrodt Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 72. Stryker Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 73. Teleflex Incorporated Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 74. Acclarent, Inc. (Johnson & Johnson) Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 75. Medtronic Revenue Growth Rate in Paralysis (Plegia) Treatment Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

以下、関連資料のご紹介

世界の睡眠麻痺治療市場規模・現状・予測（2021年-2027年）

Global Sleep Paralysis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4872 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、睡眠麻痺治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（覚醒剤、選択的セロトニン再取り込み阻害薬（SSRI）、三環系抗うつ薬、オキシベートナトリウム）、用途別市場規模（病院、家庭、介護センター、そ...

世界の周期性四肢麻痺治療市場規模・現状・予測（2021年-2027年）

Global Periodic Paralysis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4683 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、周期性四肢麻痺治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベータ遮断薬、炭酸脱水酵素阻害薬、その他）、用途別市場規模（低カリウム血症性周期性四肢麻痺、高カリウム血症性周期性四肢麻痺、甲状腺毒性...

世界の声帯麻痺治療市場規模・現状・予測（2021年-2027年）

Global Vocal Cord Paralysis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5031 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、声帯麻痺治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科治療）、用途別市場規模（片側性声帯麻痺、両側性声帯麻痺）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界の一側性声帯麻痺治療市場規模・現状・予測（2021年-2027年）

Global Unilateral Vocal Cord Paralysis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4998 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、一側性声帯麻痺治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科治療）、用途別市場規模（病院、クリニック、外科医院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の顕微鏡的多発血管炎（MPA）治療市場規模・現状・予測（2021年-2027年）

Global Microscopic Polyangiitis(MPA) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4506 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、顕微鏡的多発血管炎（MPA）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アバコパン、免疫グロブリン、リツキシマブバイオシミラー、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別...

世界の結核（TB）治療市場規模・現状・予測（2021年-2027年）

Global Tuberculosis (TB) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4987 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、結核（TB）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イソニアジド、リファンピン（リファディン、リマクタン）、エタンブトール（ミアンブトール）、ピラジナミド）、用途別市場規模（活動性結核、潜...

世界の尿素サイクル異常症（UCD）治療市場規模・現状・予測（2021年-2027年）

Global Urea Cycle Disorders (UCD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5000 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、尿素サイクル異常症（UCD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アミノ酸式、フェニル酪酸、安息香酸ナトリウム、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別...

世界の慢性難治性咳（CRC）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Refractory Cough (CRC) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5661 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、慢性難治性咳（CRC）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（言語療法、理学療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の骨髄性プロトポルフィリン症（EPP）治療市場規模・現状・予測（2021年-2027年）

Global Erythropoietic Protoporphyria (EPP) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4205 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、骨髄性プロトポルフィリン症（EPP）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン療法、補助療法、光線療法）、用途別市場規模（病院薬局、ドラッグストア、小売薬局、オンライン薬局）、主要地...

世界の原始神経外胚葉性腫瘍（PNET）治療市場規模・現状・予測（2021年-2027年）

Global Primitive Neuroectodermal Tumors (PNET) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4766 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、原始神経外胚葉性腫瘍（PNET）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科手術、化学療法、放射線療法）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリ...

世界の一側性声帯麻痺治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Unilateral Vocal Cord Paralysis Treatment Market The global Unilateral Vocal Cord Paralysis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…
世界の睡眠麻痺治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sleep Paralysis Treatment Market The global Sleep Paralysis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…
世界の声帯麻痺治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vocal Cord Paralysis Treatment Market The global Vocal Cord Paralysis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
世界の周期性四肢麻痺治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Periodic Paralysis Treatment Market The global Periodic Paralysis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
世界の一側性声帯麻痺診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Unilateral Vocal Cord Paralysis Diagnosis Market The global Unilateral Vocal Cord Paralysis Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…